News
Monsoon does not have to be misery. With habits so simple safe water, cleanliness, careful eating you can drastically ...
Vermont has the second lowest state fatality rate in the US (147.9 per 100K; Hawaii 113.5/100K). Mississippi (465.6/100K) and ...
Kylian Mbappe of Real Madrid has been hospitalized with acute gastroenteritis, a significant blow to both the team and the inaugural tournament. The i ...
Vaxart's (NASDAQ:VXRT) shares rose following the positive results from an early-stage trial of its new oral pill vaccine for norovirus, a more advanced version compared to its first-generation ...
Globally, norovirus is associated with approximately one-fifth of all diarrhea cases (Lopman BA et al 2016, with a similar prevalence in both children and adults. Norovirus is the 2nd most common ...
Vaxart, Inc., a biotechnology company focused on oral recombinant pill vaccines, announced it will release topline data from its Phase I trial on norovirus before the market opens on June 11, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results